A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma
Clinical trial NCT03470922 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03470922
- Sponsor
- Bristol-Myers Squibb
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-11
- Primary completion
- 2021-01-25
- Enrollment
- 714
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.